Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders:a review of the literature

10.1002/art.1780380817

Brief AA, 2001, Use of glucosamine and chondroitin sulfate in the management of osteoarthritis. J Am Acad Orthop Surg, 9, 71, 10.5435/00124635-200103000-00001

10.1053/sarh.2000.9622

Felson DT, 1988, Epidemiol Rev, 10, 1, 10.1093/oxfordjournals.epirev.a036019

10.1001/jama.286.2.188

10.1016/S1098-3597(01)90069-9

10.2105/AJPH.84.3.351

2002, MMWR Morb Mortal Wkly Rep, 51, 948

Tesche F, 2005, Histol Histopathol, 20, 329

10.7326/0003-4819-109-1-18

10.1038/sj.ijo.0801585

Pearle AD, 2005, Basic science of articular cartilage and osteoarthritis. Clin Sports Med, 24, 1

Kuettner KE, 1991, Thonar EJ. Articular cartilage matrix and structure: a minireview. J Rheumatol Suppl, 27, 46

Buckwalter JA, 1998, Articular cartilage. Part I: tissue design and chondrocyte-matrix interactions. Instr Course Lect, 47, 477

10.1002/art.1780080402

10.1002/jor.1100050117

10.3810/psm.2000.11.1288

Lotz M, 1995, J Rheumatol Suppl, 43, 104

Buckwalter JA, 1995, rest in the treatment of bone, soft tissue and joint injuries. Iowa Orthop J, 15, 29

Buckwalter JA, 1995, J Rheumatol Suppl, 43, 13

10.1002/jor.1100060602

10.1002/art.1780390417

10.1002/art.1780210206

Trippel SB, 1995, J Rheumatol Suppl, 43, 129

10.1203/00006450-198901000-00017

10.1002/(SICI)1097-4652(199602)166:2<351::AID-JCP13>3.0.CO;2-E

10.1002/jcp.1041380216

10.1006/abbi.1994.1489

10.1023/A:1020185404126

10.1007/s007760050123

10.1097/00003086-200003000-00018

10.1002/1529-0131(199905)42:5<1003::AID-ANR20>3.0.CO;2-K

10.1042/0264-6021:3500381

Felson DT, 1991, J Rheumatol, 18, 1587

10.1177/036354659702500624

Cushnaghan J, 1991, I. Analysis by age, sex, and distribution of symptomatic joint sites. Ann Rheum Dis, 50, 8

Osteoarthritis Dieppe P., 1991, Br J Rheumatol, 30, 1, 10.1093/rheumatology/30.1.1

Felson DT, 1990, Rheum Dis Clin North Am, 16, 499, 10.1016/S0889-857X(21)00885-1

10.1002/art.1780381104

10.1002/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P

10.1001/jama.279.9.657

10.1111/j.1365-2036.2004.02037.x

Anon, 2005, Nutrition Business J, 10, 6

10.1001/jama.283.11.1469

Setnikar I, 1986, Pharmacokinetics of glucosamine in the dog and in man. Arzneimittelforschung, 36, 729

Bassleer C, 1992, In-vitro evaluation of drugs proposed as chondroprotective agents. Int J Tissue React, 14, 231

Vidal y Plana RR, 1978, In vitro studies on glucosamine and non steroidal antiinflammatory drugs. Pharmacol Res Commun, 10, 557

10.1016/S0306-9877(98)90272-9

10.2337/diab.43.10.1173

10.2337/diabetes.48.8.1562

Shankar RR, 1998, Glucosamine infusion in rats mimics the beta-cell dysfunction of non-insulin-dependent diabetes mellitus. Metabolism, 47, 573

Biggee BA, 2004, Med Health R I, 87, 180

10.1056/NEJMoa052771

Biggee BA, 2004, Med Health R I, 87, 176

10.1016/S0889-857X(03)00064-4

10.1016/j.joca.2005.10.003

Oesser S, 2003, Cell Tissue Res, 311, 393, 10.1007/s00441-003-0702-8

Krug E, 1979, Z Erfahrungsheikunde, 11, 930

Götz B, 1982, Ärztl Prax, 92, 3130

Individuelle Oberschelp U., 1985, Therapiewoche, 44, 5094

Adam M, 1991, Ther Osteoarthrose Therapiewoche, 41, 2456

Flechsenhar K, 2005, Orthopaedische Praxis, 9, 486

Oesser S, 1999, J Nutr, 129, 1891, 10.1093/jn/129.10.1891

Oesser S, 2005, Arthritis Rheum, 52, S62